BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33190061)

  • 1. The comparative inhibitory potency of salivary mucins against human immunodeficiency virus type 1.
    McQuaid IK; Dorfman JR; Mall AS
    Virology; 2021 Jan; 553():1-8. PubMed ID: 33190061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HIV-1 activity of salivary MUC5B and MUC7 mucins from HIV patients with different CD4 counts.
    Habte HH; de Beer C; Lotz ZE; Roux P; Mall AS
    Virol J; 2010 Oct; 7():269. PubMed ID: 20946627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay.
    Habte HH; Mall AS; de Beer C; Lotz ZE; Kahn D
    Virol J; 2006 Nov; 3():99. PubMed ID: 17125499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of crude saliva and purified salivary mucins in the inhibition of the Human Immunodeficiency Virus type 1.
    Peacocke J; Lotz Z; de Beer C; Roux P; Mall AS
    Virol J; 2012 Aug; 9():177. PubMed ID: 22929306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macromolecular organization of saliva: identification of 'insoluble' MUC5B assemblies and non-mucin proteins in the gel phase.
    Wickström C; Christersson C; Davies JR; Carlstedt I
    Biochem J; 2000 Oct; 351 Pt 2(Pt 2):421-8. PubMed ID: 11023828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New monoclonal antibodies to non-glycosylated domains of the secreted mucins MUC5B and MUC7.
    Rousseau K; Wickstrom C; Whitehouse DB; Carlstedt I; Swallow DM
    Hybrid Hybridomics; 2003 Oct; 22(5):293-9. PubMed ID: 14678646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva.
    Bolscher JG; Nazmi K; Ran LJ; van Engelenburg FA; Schuitemaker H; Veerman EC; Nieuw Amerongen AV
    Eur J Oral Sci; 2002 Apr; 110(2):149-56. PubMed ID: 12013559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple components contribute to ability of saliva to inhibit influenza viruses.
    White MR; Helmerhorst EJ; Ligtenberg A; Karpel M; Tecle T; Siqueira WL; Oppenheim FG; Hartshorn KL
    Oral Microbiol Immunol; 2009 Feb; 24(1):18-24. PubMed ID: 19121065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?
    Mall AS; Habte H; Mthembu Y; Peacocke J; de Beer C
    Virol J; 2017 Oct; 14(1):192. PubMed ID: 28985745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reorganisation of the salivary mucin network by dietary components: insights from green tea polyphenols.
    Davies HS; Pudney PD; Georgiades P; Waigh TA; Hodson NW; Ridley CE; Blanch EW; Thornton DJ
    PLoS One; 2014; 9(9):e108372. PubMed ID: 25264771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of MUC7 and MUC5B in human saliva.
    Takehara S; Yanagishita M; Podyma-Inoue KA; Kawaguchi Y
    PLoS One; 2013; 8(7):e69059. PubMed ID: 23874867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher levels of salivary MUC5B and MUC7 in individuals with gastric diseases who harbor Helicobacter pylori.
    Silva DG; Stevens RH; Macedo JM; Hirata R; Pinto AC; Alves LM; Veerman EC; Tinoco EM
    Arch Oral Biol; 2009 Jan; 54(1):86-90. PubMed ID: 18817906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrated solutions of salivary MUC5B mucin do not replicate the gel-forming properties of saliva.
    Raynal BD; Hardingham TE; Thornton DJ; Sheehan JK
    Biochem J; 2002 Mar; 362(Pt 2):289-96. PubMed ID: 11853536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a major human high molecular weight salivary mucin (MG1) as tracheobronchial mucin MUC5B.
    Nielsen PA; Bennett EP; Wandall HH; Therkildsen MH; Hannibal J; Clausen H
    Glycobiology; 1997 Apr; 7(3):413-9. PubMed ID: 9147051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC7 Level As A New Saliva Risk Factor For Dental Caries In Adult Patients.
    Szkaradkiewicz-Karpińska AK; Ronij A; Goślińska-Kuźniarek O; Przybyłek I; Szkaradkiewicz A
    Int J Med Sci; 2019; 16(2):241-246. PubMed ID: 30745804
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucins MUC5B and MUC7 in minor salivary gland secretion of children and adults.
    Sonesson M; Wickström C; Kinnby B; Ericson D; Matsson L
    Arch Oral Biol; 2008 Jun; 53(6):523-7. PubMed ID: 18282555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of high-molecular-weight human salivary mucins.
    Offner GD; Troxler RF
    Adv Dent Res; 2000 Dec; 14():69-75. PubMed ID: 11842927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Mucin-7 (Muc7) Sialylation and Altered Saliva Rheology in Sjögren's Syndrome Associated Oral Dryness.
    Chaudhury NM; Proctor GB; Karlsson NG; Carpenter GH; Flowers SA
    Mol Cell Proteomics; 2016 Mar; 15(3):1048-59. PubMed ID: 26631508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage.
    Wickström C; Davies JR; Eriksen GV; Veerman EC; Carlstedt I
    Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):685-93. PubMed ID: 9729478
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Chahal G; Quintana-Hayashi MP; Gaytán MO; Benktander J; Padra M; King SJ; Linden SK
    Front Cell Infect Microbiol; 2022; 12():889711. PubMed ID: 35782137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.